D
DNLI//CIK 0001714899
Denali Therapeutics Inc.
Market Data
$20.65−$0.35 (−1.67%)
DNLI · Last trade
Prev Close
$21.00
Range (30d)
$18.08 – $22.47
Recent Filings
- 8-K218.6 KBDenali Therapeutics Inc.Apr 3, 2:43 PM ET·0001714899-26-000042
- 8-K142.5 KBDenali Therapeutics Inc.Mar 31, 8:30 AM ET·0001714899-26-000036
- 8-K258.3 KBDenali Therapeutics Inc.Mar 25, 3:13 PM ET·0001714899-26-000030
- 10-K24.8 MBDenali Therapeutics Inc.Feb 26, 4:11 PM ET·0001714899-26-000021
- 8-K299.8 KBDenali Therapeutics Inc.Feb 26, 4:07 PM ET·0001714899-26-000020
- 8-K242.7 KBDenali Therapeutics Inc.Jan 6, 8:02 AM ET·0001714899-26-000004
- 8-K813.9 KBDenali Therapeutics Inc.Dec 10, 5:21 PM ET·0001628280-25-056363
- 8-K20.0 MBDenali Therapeutics Inc.Dec 4, 7:01 AM ET·0001714899-25-000209
- 8-K274.1 KBDenali Therapeutics Inc.Dec 4, 7:01 AM ET·0001714899-25-000208
- 10-Q6.4 MBDenali Therapeutics Inc.Nov 6, 4:05 PM ET·0001714899-25-000193
Insiders
10- 667, L.P.Director
- AFEYAN NOUBAR10% Owner
- ARCH Venture Fund VIII, L.P.10% Owner
- ARCH Venture Partners VIII, LLC10% Owner
- ARCH Venture Partners VIII, L.P.10% Owner
- Baker Bros. Advisors (GP) LLCDirector
- BAKER BROS. ADVISORS LPDirector
- Baker Brothers Life Sciences LPDirector
- BAKER FELIXDirector
- BAKER JULIANDirector
Tickers
Addresses
business
161 OYSTER POINT BLVD.
SOUTH SAN FRANCISCO, CA, 94080
mailing
161 OYSTER POINT BLVD.
SOUTH SAN FRANCISCO, CA, 94080